SEC 13F Intelligence

Aquilo Capital Management, LLC / CCCC

Aquilo Capital Management, LLC’s C4 Therapeutics Inc Position

Does Aquilo Capital Management, LLC own C4 Therapeutics Inc (CCCC)? Not currently — the last reported position was 1.99M shares worth $4M in Q3 2023; the fund’s latest 13F (Q3 2025) no longer reports it.

Position Value
$4M
Q3 2023
Shares
1.99M
% of Portfolio
+3.35%
Quarters Held
2
position exited

Position History CCCC

Reported value by quarter
Q2 ’23: $2MQ2 ’23Q3 ’23: $4MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20231.99M$4M+3.35%
Q2 2023760.7K$2M+1.16%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aquilo Capital Management, LLC’s full portfolio or all institutional holders of CCCC.